Other
Severance accrual, current
Gilead Sciences Severance accrual, current increased by 40.4% to $73.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase signals active cost-cutting or organizational restructuring, while a decrease indicates the completion of such programs.
Detailed definition
This represents the current portion of estimated costs associated with restructuring activities, such as severance payme...
Peer comparison
Common in industrial conglomerates undergoing periodic operational optimization; varies significantly based on restructuring cycles.
Metric ID:
other_restructuring_reserve_currentHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $138.00M | $92.00M | $52.00M | $73.00M |
| QoQ Change | — | -33.3% | -43.5% | +40.4% |
| YoY Change | — | — | — | -47.1% |
Range$52.00M – $138.00M
Avg YoY Growth-47.1%
Median YoY Growth-47.1%
Severance accrual, current at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's severance accrual, current?
- Gilead Sciences (GILD) reported severance accrual, current of $73.00M in Q1 2026.
- What does severance accrual, current mean?
- The amount of money set aside for severance and restructuring costs expected to be paid within the next year.